AbbVie Inc. (NYSE: ABBV) reported better-than-expected results for the second quarter of 2020 on Friday. The company reported a 26% increase in
Strong performance of oncology products bode well for AbbVie (ABBV) going forward
Categories
Health Care
Molina Healthcare Inc (MOH) Q2 2020 Earnings Call Transcript
Molina Healthcare Inc (NYSE: MOH) Q2 2020 earnings call dated July 31, 2020 Corporate Participants: Julie Trudell -- Senior Vice President of Investor Relations
Immunogen Inc. (IMGN) Q2 2020 Earnings Call Transcript
Immunogen Inc (NASDAQ: IMGN) Q2 2020 earnings call dated July 31, 2020 Corporate Participants: Courtney O'Konek -- Senior Director of Corporate Communications and Investor
ImmunoGen (IMGN) Earnings: 2Q20 Key Numbers
ImmunoGen Inc. (NASDAQ: IMGN) reported second quarter 2020 earnings results today. Revenues were $15 million, compared to $15.5 million in the prior-year period. Net loss
Merck & Co., Inc. (MRK) Q2 2020 Earnings Call Transcript
Merck & Co., Inc. (NYSE: MRK) Q2 2020 earnings call dated July 31, 2020 https://youtu.be/kKm2dyqbeW0 Corporate Participants: Peter Dannenbaum -- Vice President of Investor
Eli Lilly & Co. (LLY) Q2 2020 Earnings Call Transcript
Eli Lilly & Co. (NYSE: LLY) Q2 2020 earnings call dated July 30, 2020 https://www.youtube.com/watch?v=d4-cSFo067A Presentation: Operator Ladies and gentlemen, thank you
Baxter International Inc. (BAX) Q2 2020 Earnings Call Transcript
Baxter International Inc. (NYSE: BAX) Q2 2020 earnings call dated Jul. 30, 2020 Corporate Participants: Clare Trachtman -- Vice President, Investor Relations Jose (Joe)
AbbVie (ABBV) Q2 2020 results beat estimates; updates FY20 outlook
AbbVie (NYSE: ABBV), which completed the acquisition of Allergan on May 8, 2020, reported second quarter 2020 earnings results today. The company's
Merck (MRK) sales decline 8% in Q2 2020; raises FY20 outlook
Merck (NYSE: MRK) reported an 8% drop in second quarter sales, reflecting the negative impact of COVID-19. However, sales of $10.9 billion
Vertex Pharmaceuticals Inc. (VRTX) Q2 2020 Earnings Call Transcript
Vertex Pharmaceuticals Inc (NASDAQ: VRTX) Q2 2020 earnings call dated July 30, 2020 Corporate Participants: Michael Partridge -- Senior Vice President, Investor Relations Reshma
Gilead Sciences Inc. (GILD) Q2 2020 Earnings Call Transcript
Gilead Sciences Inc (NASDAQ: GILD) Q2 2020 earnings call dated July 30, 2020 Corporate Participants: Douglas Maffei -- Senior Director, Investor Relations Daniel O'Day -- Chairman
Infographic: Highlights from Gilead Sciences (GILD) Q2 2020 earnings
Gilead Sciences (NASDAQ: GILD) reported second-quarter financial results after the closing bell on Thursday. The biotechnology firm missed both the revenue and
Cigna Corp (CI) Q2 2020 Earnings Call Transcript
Cigna Corp (NYSE: CI) Q2 2020 earnings call dated July 30, 2020 Corporate Participants: William McDowell -- Vice President, Investor Relations David M. Cordani -- President
AstraZeneca PLC (AZN) Q2 2020 Earnings Call Transcript
AstraZeneca PLC (NYSE: AZN) Q2 2020 earnings call dated July 30, 2020 Corporate Participants: Pascal Soriot -- Executive Director and Chief Executive Officer Dave
Anthem Inc (ANTM) Q2 2020 Earnings Call Transcript
Anthem Inc (NYSE: ANTM) Q2 2020 earnings call dated July 29, 2020 Corporate Participants: Chris Rigg -- Vice President Investor Relations Gail Boudreaux -- President and
LLY Earnings: All you need to know about Eli Lilly Q2 2020 earnings results
Eli Lilly and Company (NYSE: LLY) reported second quarter 2020 earnings results today. Revenues declined 2% year-over-year to $5.4 billion. Reported net
Amgen Inc. (AMGN) Q2 2020 Earnings Call Transcript
Amgen Inc (NASDAQ: AMGN) Q2 2020 earnings call dated July 28, 2020 Corporate Participants: Arvind Sood -- Vice President of Investor Relations Robert A.
Pfizer Inc. (PFE) Q2 2020 Earnings Call Transcript
Pfizer Inc. (NYSE: PFE) Q2 2020 earnings call dated July 28, 2020 https://youtu.be/aJVrijDiyOk Corporate Participants: Chuck Triano -- Senior Vice President, Investor Relations Albert
Pfizer (PFE) raises outlook on hopes of prescription trends recovery and COVID-19 vaccine progress
Shares of Pfizer Inc. (NYSE: PFE) were up more than 4% on Tuesday after the company beat revenue and earnings estimates for
Key highlights from Pfizer (PFE) Q2 2020 earnings results
Pfizer Inc. (NYSE:PFE) reported second quarter 2020 earnings results today. Revenues fell 11% to $11.8 billion. The decline was 9% on an
Trxade Group Inc. (MEDS) Q2 2020 Earnings Call Transcript
Trxade Group Inc. (NASDAQ: MEDS) Q2 2020 earnings call dated July 27, 2020 Corporate Participants: Suren Ajjarapu -- Founder, Chairman and Chief Executive Officer